When federal regulators last week approved Digene Corp.'s cervical cancer test as a primary screening tool for women over 30, they catapulted what had been a follow-up test into direct competition ...
Digene Corp., which makes a screening test for cervical cancer, said yesterday that it had struck a deal with a Texas biotech company to sell a genetic test for identifying carriers of cystic fibrosis ...
NEW YORK, Jan 12 (Reuters) - Digene Corp's new chief executive officer said on Friday the company could not afford to remain "a one-product company" and would aim to disclose a strategy of moving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results